Tag: biosimilars billing
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Proton Pump Inhibitors and Antifungals: How Acid Blockers Sabotage Absorption
Aug, 3 2026
Deficiency Letters in Generic Drug Applications: Common FDA Findings and How to Avoid Them
Jan, 16 2026
IBS-Mixed: How to Manage Alternating Constipation and Diarrhea
Jan, 3 2026
Dermatomyositis and Polymyositis: Symptoms, Diagnosis, and Modern Treatment Options
Jul, 20 2026
How and Where to Buy Estrace Online Safely (2025 Guide)
Aug, 21 2025